Protagonist Therapeutics Inc PTGX:NASDAQ

Last Price$11.40NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$10.90 (1)
Ask (Size)$11.53 (5)
Day Low / HighN/A - N/A
Volume957.5 K

Top Midday Decliners

1:58PM ET 4/14/2022 MT Newswires
Protagonist Therapeutics (PTGX) said it received a letter from the Food and Drug Administration indicating the regulator's intention to rescind Breakthrough Therapy Designation for its drug candidate rusfertide to treat polycythemia vera, a rare blood disorder.

Shares of the healthcare firm slumped 20% by Thursday afternoon as trading volume jumped to more than 3.6 million from its daily average of about 729,000.

Evolving Systems (EVOL) said it formally notified the Nasdaq Stock Market of its plan for a voluntarily delisting.

The supplier to wireless carrier and consumer financial service markets expects its last trading day on Nasdaq to be on or about May 5. Shares sank 20% after trading volume increased to over 509,000 versus its daily average of more than 85,000.

Cambium Networks (CMBM) lowered its Q1 revenue outlook to be between $61 million and $63 million from the previous $77.5 million to $81.5 million guidance.

Shares of the provider wireless broadband networking infrastructure slumped more than 16% as trading volume increased to over 693,000 from about 193,000.